10-Q Filing

MERCK & CO., INC. CIK: 310158 Q3 2018

Filing Information

Form Type	10-Q
Accession Number	`0000310158-18-000039`
Period End Date	20180930
Filing Date	20181106
Fiscal Year	2018
Fiscal Period	Q3
XBRL Instance	mrk-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 56 Cash Flow Statement 64 Comprehensive Income 28

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$229.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$210.00M	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.29B	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.19B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.60B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.57B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.09B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.83B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.41B	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.46B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $229 in 2018 and $210 in 2017)	`AccountsReceivableNetCurrent`	$7.37B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $229 in 2018 and $210 in 2017)	`AccountsReceivableNetCurrent`	$6.87B	USD	Point-in-time
Inventories (excludes inventories of $1,294 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)	`InventoryNet`	$5.10B	USD	Point-in-time
Inventories (excludes inventories of $1,294 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)	`InventoryNet`	$5.42B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$4.30B	USD	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$3.76B	USD	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	918.36M	shares	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	880.49M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$26.84B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.77B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$7.61B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$12.12B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,568 in 2018 and $16,602 in 2017	`PropertyPlantAndEquipmentNet`	$12.44B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,568 in 2018 and $16,602 in 2017	`PropertyPlantAndEquipmentNet`	$12.76B	USD	Point-in-time
Goodwill	`Goodwill`	$18.28B	USD	Point-in-time
Goodwill	`Goodwill`	$18.26B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$14.18B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$12.18B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$7.50B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$6.08B	USD	Point-in-time
Total Assets	`Assets`	$87.87B	USD	Point-in-time
Total Assets	`Assets`	$85.13B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$3.66B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$3.06B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$3.09B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$3.10B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$9.78B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$10.43B	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$759.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$708.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.32B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.30B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.61B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.59B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$21.35B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$19.94B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.22B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.06B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$11.89B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$11.12B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017	`CommonStockValue`	$1.79B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017	`CommonStockValue`	$1.79B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.76B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.90B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$42.19B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$41.35B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.15B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.91B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$78.59B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$78.13B	USD	Point-in-time
Less treasury stock, at cost: 918,364,126 shares in 2018 and 880,491,914 shares in 2017	`TreasuryStockValue`	$43.79B	USD	Point-in-time
Less treasury stock, at cost: 918,364,126 shares in 2018 and 880,491,914 shares in 2017	`TreasuryStockValue`	$46.17B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$34.34B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$32.42B	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$233.00M	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$234.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$40.31B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$32.66B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.50B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$39.71B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$32.77B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$34.57B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$87.87B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$85.13B	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Sales	`Revenues`	$10.79B	USD	1 Quarter
Sales	`Revenues`	$29.69B	USD	3 Qtrs
Sales	`Revenues`	$31.30B	USD	3 Qtrs
Sales	`Revenues`	$10.32B	USD	1 Quarter
Materials and production	`CostOfGoodsAndServicesSold`	$9.47B	USD	3 Qtrs
Materials and production	`CostOfGoodsAndServicesSold`	$3.62B	USD	1 Quarter
Materials and production	`CostOfGoodsAndServicesSold`	$10.22B	USD	3 Qtrs
Materials and production	`CostOfGoodsAndServicesSold`	$3.31B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.46B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.44B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$7.46B	USD	3 Qtrs
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$7.43B	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$7.54B	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.07B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.02B	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.41B	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$153.00M	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$470.00M	USD	3 Qtrs
Restructuring costs	`RestructuringCharges`	$494.00M	USD	3 Qtrs
Restructuring costs	`RestructuringCharges`	$171.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$351.00M	USD	3 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$172.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$512.00M	USD	3 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$207.00M	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$25.05B	USD	3 Qtrs
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$10.12B	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$25.20B	USD	3 Qtrs
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$8.13B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.10B	USD	3 Qtrs
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$200.00M	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.64B	USD	3 Qtrs
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.67B	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$1.19B	USD	3 Qtrs
Taxes on Income	`IncomeTaxExpenseBenefit`	$707.00M	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$251.00M	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$1.68B	USD	3 Qtrs
Net Income (Loss)	`ProfitLoss`	$-51.00M	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$4.42B	USD	3 Qtrs
Net Income (Loss)	`ProfitLoss`	$3.46B	USD	3 Qtrs
Net Income (Loss)	`ProfitLoss`	$1.96B	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$22.00M	USD	3 Qtrs
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.00M	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00M	USD	3 Qtrs
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.95B	USD	1 Quarter
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$-56.00M	USD	1 Quarter
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$4.39B	USD	3 Qtrs
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.44B	USD	3 Qtrs
Basic Earnings (Loss) per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Basic Earnings (Loss) per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.64	USD	3 Qtrs
Basic Earnings (Loss) per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.73	USD	1 Quarter
Basic Earnings (Loss) per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.26	USD	3 Qtrs
Earnings (Loss) per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.25	USD	3 Qtrs
Earnings (Loss) per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.63	USD	3 Qtrs
Earnings (Loss) per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Earnings (Loss) per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.73	USD	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCashAndCashEquivalents`	$4.00M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$2.00M	USD	Point-in-time
Net income	`ProfitLoss`	$-51.00M	USD	1 Quarter
Net income	`ProfitLoss`	$4.42B	USD	3 Qtrs
Net income	`ProfitLoss`	$3.46B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.96B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.51B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.42B	USD	3 Qtrs
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$376.00M	USD	3 Qtrs
Charge for future payments related to collaboration license options	`ChargeForLicenseOptionsRelatedToCollaboration`	$650.00M	USD	3 Qtrs
Charge for future payments related to collaboration license options	`ChargeForLicenseOptionsRelatedToCollaboration`	$750.00M	USD	3 Qtrs
Charge for collaboration termination	`GainLossOnContractTermination`	-	USD	3 Qtrs
Charge for collaboration termination	`GainLossOnContractTermination`	$-420.00M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-601.00M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-391.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$261.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$91.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$76.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$232.00M	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$31.00M	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$-585.00M	USD	3 Qtrs
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$5.26B	USD	3 Qtrs
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$2.03B	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$7.33B	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$2.43B	USD	3 Qtrs
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$1.69B	USD	3 Qtrs
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$1.17B	USD	3 Qtrs
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$6.90B	USD	3 Qtrs
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$8.40B	USD	3 Qtrs
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$12.53B	USD	3 Qtrs
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$11.24B	USD	3 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$347.00M	USD	3 Qtrs
Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$372.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$150.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-121.00M	USD	3 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$2.14B	USD	3 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$2.74B	USD	3 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$1.96B	USD	3 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$2.29B	USD	3 Qtrs
Payments on debt	`RepaymentsOfLongTermDebt`	$301.00M	USD	3 Qtrs
Payments on debt	`RepaymentsOfLongTermDebt`	$3.01B	USD	3 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$3.16B	USD	3 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$2.31B	USD	3 Qtrs
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$3.88B	USD	3 Qtrs
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$3.90B	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$461.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$481.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-289.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-167.00M	USD	3 Qtrs
Net Cash Used in Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.22B	USD	3 Qtrs
Net Cash Used in Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.59B	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$438.00M	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-140.00M	USD	3 Qtrs
Net Increase in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.39B	USD	3 Qtrs
Net Increase in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.73B	USD	3 Qtrs
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.83B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $2 million at September 30, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $2 million at September 30, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $2 million at September 30, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $2 million at September 30, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.83B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.95B	USD	1 Quarter
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$-56.00M	USD	1 Quarter
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$4.39B	USD	3 Qtrs
Net Income (Loss) Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.44B	USD	3 Qtrs
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$27.00M	USD	1 Quarter
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-441.00M	USD	3 Qtrs
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-66.00M	USD	1 Quarter
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$223.00M	USD	3 Qtrs
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-56.00M	USD	3 Qtrs
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$213.00M	USD	3 Qtrs
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$135.00M	USD	1 Quarter
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$40.00M	USD	1 Quarter
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-106.00M	USD	3 Qtrs
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-86.00M	USD	3 Qtrs
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-40.00M	USD	1 Quarter
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-13.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$67.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-240.00M	USD	3 Qtrs
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-136.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$423.00M	USD	3 Qtrs
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$149.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$33.00M	USD	3 Qtrs
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-29.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$281.00M	USD	3 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$3.72B	USD	3 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$1.92B	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$4.43B	USD	3 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$93.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.